Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-024351

Chief Discovery/Trans Medicine sold 3,000 shares at $35.53 ($106,590)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamilton James C Chief Discovery/Trans Medicine 2023-06-30 Sale −3,000 $35.53 $106,590 188,484 D
Open-market sales · 3,000 sh · avg $35.53 · $106,590
Loading xslF345X04/wk-form4_1688595303.xml…